AssayIndex

KP-2312-R4578

Sermorelin · 15 mg declared · Zhuhai Kerui Biotechnology Co., Ltd. · manufactured 20 Dec 2023

CHARACTERISED
Lot code
KP-2312-R4578
Supplier
KP — Zhuhai Kerui Biotechnology Co., Ltd.
Compound
Sermorelin
Compound class
Growth-hormone axis peptides
Declared label claim
15mg
Manufacture date
20 Dec 2023
Index quarter
2024-Q2
Independent assays
10
Laboratories involved
Janoshik, Medutest, Nordanalyt, VendorInvestigate
Provenance mix
Buyer-sourced ×1 · Supplier-supplied ×8 · Laboratory-retained ×1
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 10
Median purity 99.25% n=10
Spread (max − min) 1.29pp n=10
Standard deviation 0.433pp n=10
97.497.898.398.799.199.6100.0This lot (KP-2312-R4578)This lot (KP-2312-R4578): Q1 98.88, median 99.25, Q3 99.34, n=10n=10All SermorelinAll Sermorelin: Q1 98.39, median 98.94, Q3 99.22, n=96n=96 Purity (% area)
Figure 1. This lot's independent purity results against the whole Sermorelin record set in the index. The vertical line is the index acceptance specification for the growth-hormone axis peptides class, 98.0 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 10

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-005124KP-2312-R4578Janoshik2024-Q299.256.7793.7Supplier-supplied0PASS
AX-2024-005125KP-2312-R4578Janoshik2024-Q299.507.05Supplier-supplied0PASS
AX-2024-005126KP-2312-R4578Janoshik2024-Q298.807.25100.5Supplier-supplied1MARGINAL
AX-2024-005127KP-2312-R4578Medutest2024-Q299.367.55102.2Supplier-supplied1FAIL
AX-2024-005128KP-2312-R4578Medutest2024-Q299.107.4696.2Supplier-supplied0PASS
AX-2024-005129KP-2312-R4578Nordanalyt2024-Q299.296.49Supplier-supplied0PASS
AX-2024-005130KP-2312-R4578Janoshik2024-Q299.577.3189.1Supplier-supplied1MARGINAL
AX-2024-005131KP-2312-R4578VendorInvestigate2024-Q298.476.84Buyer-sourced0PASS
AX-2024-005132KP-2312-R4578Janoshik2024-Q299.247.04Supplier-supplied0PASS
AX-2024-005133KP-2312-R4578Medutest2024-Q298.287.26Laboratory-retained0PASS
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
Janoshik599.25, 99.50, 98.80, 99.57, 99.2499.2530min+0.0099.25
Medutest399.36, 99.10, 98.2899.1025min+0.0899.02
Nordanalyt199.2999.2935min+0.0299.27
VendorInvestigate198.4798.4732min-0.1198.58

This lot contributes 6 paired comparisons to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)99.0699.25divergence -0.19 pp vs batch median
Total impurities (% area)not stated0.75
Largest single impurity (% area)not stated0.27
Water (%)5.76.77
Counter-ion (%)not stated3.99
Peptide content (%w/w)89.588.75
Endotoxin (EU/mg)not stated0.36
Method stated on certificateNOno method section — the result cannot be reconciled against any other
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
des-Tyr1 (−163 Da)10 / 100.210.06–0.42
aspartimide (−18 Da)10 / 100.240.11–0.38
deamidated Asn8 (+1 Da)10 / 100.190.09–0.48
truncated (1-25)10 / 100.170.05–0.64
Section 7

What this rollup does not establish